195 related articles for article (PubMed ID: 34042449)
1. Focused Libraries for Epigenetic Drug Discovery: The Importance of Isosteres.
Green AI; Burslem GM
J Med Chem; 2021 Jun; 64(11):7231-7240. PubMed ID: 34042449
[TBL] [Abstract][Full Text] [Related]
2. Open access chemical probes for epigenetic targets.
Brown PJ; Müller S
Future Med Chem; 2015; 7(14):1901-17. PubMed ID: 26397018
[TBL] [Abstract][Full Text] [Related]
3. Targeting epigenetic reader domains by chemical biology.
Cipriano A; Sbardella G; Ciulli A
Curr Opin Chem Biol; 2020 Aug; 57():82-94. PubMed ID: 32739717
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of Protein Methyltransferases and Demethylases.
Kaniskan HÜ; Martini ML; Jin J
Chem Rev; 2018 Feb; 118(3):989-1068. PubMed ID: 28338320
[TBL] [Abstract][Full Text] [Related]
6. Medicinal chemistry insights in the discovery of novel LSD1 inhibitors.
Wang X; Huang B; Suzuki T; Liu X; Zhan P
Epigenomics; 2015; 7(8):1379-96. PubMed ID: 26646727
[TBL] [Abstract][Full Text] [Related]
7. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
[TBL] [Abstract][Full Text] [Related]
8. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
Bayo J; Dalvi MP; Martinez ED
Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Antibody-Based Activity Assay for Lysine Specific Demethylase 1 (LSD1) on a Histone Peptide Substrate.
Schmitt ML; Ladwein KI; Carlino L; Schulz-Fincke J; Willmann D; Metzger E; Schilcher P; Imhof A; Schüle R; Sippl W; Jung M
J Biomol Screen; 2014 Jul; 19(6):973-8. PubMed ID: 24687155
[TBL] [Abstract][Full Text] [Related]
10. Privileged structures: efficient chemical "navigators" toward unexplored biologically relevant chemical spaces.
Kim J; Kim H; Park SB
J Am Chem Soc; 2014 Oct; 136(42):14629-38. PubMed ID: 25310802
[TBL] [Abstract][Full Text] [Related]
11. Chemical Control System of Epigenetics.
Vaijayanthi T; Pandian GN; Sugiyama H
Chem Rec; 2018 Dec; 18(12):1833-1853. PubMed ID: 30378269
[TBL] [Abstract][Full Text] [Related]
12. Computational Analysis and Predictive Cheminformatics Modeling of Small Molecule Inhibitors of Epigenetic Modifiers.
Jamal S; Arora S; Scaria V
PLoS One; 2016; 11(9):e0083032. PubMed ID: 27622288
[TBL] [Abstract][Full Text] [Related]
13. Histone methylases as novel drug targets: developing inhibitors of EZH2.
Baugé C; Bazille C; Girard N; Lhuissier E; Boumediene K
Future Med Chem; 2014; 6(17):1943-65. PubMed ID: 25495986
[TBL] [Abstract][Full Text] [Related]
14. Scaffold Diversity Synthesis and Its Application in Probe and Drug Discovery.
Garcia-Castro M; Zimmermann S; Sankar MG; Kumar K
Angew Chem Int Ed Engl; 2016 Jun; 55(27):7586-605. PubMed ID: 27187638
[TBL] [Abstract][Full Text] [Related]
15. Screening Library Design.
Ashenden SK
Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic assays for chemical biology and drug discovery.
Gul S
Clin Epigenetics; 2017; 9():41. PubMed ID: 28439316
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic drug target deconvolution by mass spectrometry-based technologies.
Noberini R; Bonaldi T
Nat Struct Mol Biol; 2019 Oct; 26(10):854-857. PubMed ID: 31582842
[TBL] [Abstract][Full Text] [Related]
18. Photochemical synthesis of an epigenetic focused tetrahydroquinoline library.
Green AI; Burslem GM
RSC Med Chem; 2021 Oct; 12(10):1780-1786. PubMed ID: 34778779
[TBL] [Abstract][Full Text] [Related]
19. Chemical probes and drug leads from advances in synthetic planning and methodology.
Gerry CJ; Schreiber SL
Nat Rev Drug Discov; 2018 May; 17(5):333-352. PubMed ID: 29651105
[TBL] [Abstract][Full Text] [Related]
20. Natural Product-Derived Spirooxindole Fragments Serve as Privileged Substructures for Discovery of New Anticancer Agents.
Yu B; Zheng YC; Shi XJ; Qi PP; Liu HM
Anticancer Agents Med Chem; 2016; 16(10):1315-24. PubMed ID: 26522954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
